Evaxion A EVAX
NASDAQ EVAX
$3.18 -0.10 (-3.05%)
At close: Oct 1, 2026 · 4:00 PM EDT

Evaxion A (EVAX) Net Equity Issued and Repurchased (2021)

Updated

Evaxion A (EVAX) recorded Net Equity Issued and Repurchased of $2.59 million in FY2023.

Analysis

Evaxion A (EVAX) Net Equity Issued and Repurchased (2021) Analysis & Trends

Starting with FY2018, Evaxion A's Net Equity Issued and Repurchased history includes 4 years.

  • Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of 18.8% (FY2018 to FY2023).
  • The FY2023 figure is the highest annual Net Equity Issued and Repurchased since FY2020.
  • Per Business Quant data, EVAX's Net Equity Issued and Repurchased was $9.02 million in FY2020 (-4.5%) and $9.44 million in FY2019 (+764.7%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Evaxion A 21.02 Mn -45.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 27.90 Mn
API Access

Evaxion A Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=EVAX&period=max&api_key=YOUR_API_KEY